The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Cell & Gene
    • Bioprocessing
    • Drug Delivery
    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Regulation & Standards
    • Small Molecules
    • Supply Chain
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • eBooks
    • Content Hubs
Subscribe
Subscribe
The Medicine Maker / Issues / 2025 / November / Understanding the Benefits of Gelatin and Collagen
Formulation Development & Clinical Small Molecules Sponsored

Understanding the Benefits of Gelatin and Collagen

Check out our interview from CPHI Frankfurt featuring GELITA’s Samy Jandall

11/27/2025 0 min read Video

Sponsored By

Share

What important roles do gelatin and collagen play in biomedical applications? And why are endotoxin controlled excipients so important? Find out in this interview with Samy Jandall, GVP Global Business Management at the GELITA Group.

Newsletters

Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Recommended

Related Content

Musings from The Power List: Daniel Vitt
Small Molecules Drug Discovery Development & Clinical
Musings from The Power List: Daniel Vitt

August 20, 2026

6 min read

From multiple sclerosis to AI-driven discovery, Daniel Vitt reflects on the future of drug development

The Road to Commercial-Scale iPSC Cell Therapy
Cell & Gene Development & Clinical Interviews
The Road to Commercial-Scale iPSC Cell Therapy

August 19, 2026

5 min read

Can iPSC platforms deliver consistent, commercial-scale cell therapies for large patient populations?

The Mindset for Success in Biopharma's New Multipolar World
Biopharma Development & Clinical Outsourcing
The Mindset for Success in Biopharma's New Multipolar World

August 18, 2026

10 min read

From collapsing legacy models to the rise of Chinese biotech, industry leaders are being forced to rethink how drugs are developed, funded, and brought to market

Musings from The Power List: John Maher
Cell & Gene Power List Development & Clinical
Musings from The Power List: John Maher

August 14, 2026

4 min read

John Maher discusses the scientific and practical challenges of bringing CAR T-cell therapies to patients with solid tumors

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions: